Skip to content
AdobeStock_302075059 AdobeStock_302075059

Enhanced Centralized Monitoring with Precision

Increase data integrity with our centralized monitoring and scientific data review experts.
By harnessing advanced analytics and a unique review approach designed to support high quality data cross functionally, our Centralized Monitoring team turns complex trial data into actionable insights, ensuring your research is guided by clarity and precision. Discover how our expertise in data integration, analysis, and interpretation can streamline your clinical journey, enhancing efficiency and accelerating your path to success.
Tumor_data

Integrated data review enhanced with therapeutic insights

Precision's Centralized Monitoring team stands as a guardian of scientific rigor in clinical trials, applying therapeutic-specific standards to enhance data fidelity. Our team's nuanced approach to complex data review transcends traditional checks, providing an ongoing, holistic analysis that standard aggregate review processes cannot achieve. By interweaving centralized scientific expertise within an integrated data review process to support the multidisciplinary team, Precision preemptively identifies and mitigates risks, protecting data quality, supporting timelines and facilitating informed decision-making throughout the study lifecycle.

  • Adherence to therapeutic-specific guidelines and standards like RECIST v1.1, iRECIST, itRECIST, IMWG, Lugano, etc. for accuracy in data interpretation.
  • Study wide consistency in adverse event reporting and compliance to CTCAE criteria.
  • Manual scrutiny of intricate data sets, catching nuances beyond the scope of programmed DM edit checks.
  • Proactive detection of complex data quality issues and site concerns, averting potential risks.
  • Collaborative efforts across Medical, Data Management, Biostatistics, Medical Writing, Clinical and Project Management teams to maintain data integrity.
  • Mastery in utilizing real-time data analytics to drive quality outcomes and support pivotal trial decisions.

The Centralized Monitoring team at Precision for Medicine is not only defined by its cutting-edge solutions but also by the depth of its therapeutic experience. With years of research and clinical expertise, our global team consistently delivers with the commitment and knowledge that sets Precision apart in the industry.

20 Avg. years research experience
15 Avg. years oncology experience
20 Global team members
8 Avg. years with Precision

Centralized monitoring’s impact from start-up to close-out

Embark on a guided tour of Precision’s Centralized Monitoring team’s support throughout your study’s lifecycle. As part of our Integrated Data Review process, each stage, from start-up to database lock, is fortified with strategic data review and analysis supported by bespoke data visualization tools designed to navigate the intricacies of clinical data and leverage our team’s therapeutic expertise to your benefit. Engage with the interactive content that illustrates how Precision’s dedicated support enhances each pivotal stage, culminating in data-rich insights that illuminate your path to the next phase of development or submission.
  • Start-Up

    Start-Up

    Lay the Groundwork for Data Precision

    CSAI's engagement begins with providing clinical and scientific expertise to the EDC build and associated study procedure manuals, ensuring that the study starts on solid ground with a focus on data capture aligned to the indication, protocol requirements and future analysis.
  • Conduct

    Conduct

    Centralized, Holistic, Scientific Review Navigating Complexity During Conduct

    Data review & visualization tools designed to support the conduct of centralized, holistic, scientific data review in real time like Smart Patient Profiles™ and All Patient Data Workbook come into play, offering critical  insights for informed decision-making. Our scientific data review approach is the “secret ingredient” within our Integrated Data Review process specifically designed to address the industry gaps that result in inefficient monitoring visits and the late identification of complex issues that cannot be observed with the standard aggregate data cleaning approach or CRA form-by-form SDV but are significantly impactful to overall data quality, timelines and frustrating to study sites. Rigorous risk assessment & mitigation strategies are implemented, alongside team support & training to uphold data integrity.
    Precision’s Patient Review Tracker enables efficient monitoring of data trends and metrics. 
  • Lock

    Lock

    Securing Data Integrity at Database Lock

    Holistic, centralized, full patient profile reviews verify data accuracy throughout study conduct supporting on time locking of the database. Early and ongoing review at the patient level centrally, prevents the late identification of complex data issues that may also impact source document verification resulting in the need for additional monitoring visits and timeline delays. Final Medical Review, which is pivotal for study conclusions and regulatory submissions, is a streamlined process with Precision’s Centralized Monitoring team.
  • Precision Difference

    Precision Difference

    The Precision Edge in Data Excellence

    By the time you reach database lock, our team’s support has helped ensure that your study is finalized with cleaner data and deeper insights, setting the stage for a smoother transition to the next phase of your drug's development journey.

Insights from Precision’s experts

Stay ahead with the latest insights from Precision’s team of experts. Discover valuable perspectives, updates, and strategies to navigate early and late phase development.  

Read: Clinical Trial Site Selection: Key Challenges & Solutions for Phase 3 Success Clinical Trial Site Selection: Key Challenges & Solutions for Phase 3 Success

Clinical Trial Site Selection: Key Challenges & Solutions for Phase 3 Success

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=169565849890, hs_child_table_id=0, hs_updated_at=1723217327146, hs_published_at=1744844126301, avatar=Image{width=800,height=800,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Barbara%20Kathage.jpg',altText='Barbara Kathage',fileId=168426405902}, lastname=Kathage, hs_initial_published_at=1718988967067, hs_created_by_user_id=26433386, hs_created_at=1717603865843, hs_is_edited=false, hs_deleted_at=0, name=Barbara, job=Vice President, Site Start Up, slug=barbara-kathage, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Barbara Kathage avatar

    Barbara Kathage

Discover
Read: FDA's Vision for Multiregional Clinical Trials in Oncology FDA's Vision for Multiregional Clinical Trials in Oncology

Clinical Trials - Regulatory - Oncology

FDA's Vision for Multiregional Clinical Trials in Oncology

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=167363064857, hs_child_table_id=0, hs_updated_at=1719905898183, hs_published_at=1744844126301, description=Industry-leading oncologist and demonstrated medical leader in precision medicine, novel trial design and innovative regulatory initiatives designed to expedite drug approvals. Draws on nearly a decade leading oncology and rare disease programs at the FDA. Former fellow at the National Cancer Institute and frequent featured speaker at ASCO and AACR. CDER technical authority on oncologic drug and biological products for thoracic and head and neck malignancies, neurologic tumors, pediatric solid tumors and rare tumors., avatar=Image{width=553,height=580,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Harpreet-Singh2.png',altText='Harpreet-Singh2',fileId=171747124346}, linkedin=https://www.linkedin.com/in/harpreetsinghmd/, team=[{id=163072475007, name='Precision for Medicine Leadership'}], lastname=Singh, MD, hs_initial_published_at=1715692570942, hs_created_by_user_id=2737751, hs_created_at=1715692477118, hs_is_edited=false, hs_deleted_at=0, name=Harpreet, job=Chief Medical Officer, slug=harpreet-singh, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Harpreet Singh, MD avatar

    Harpreet Singh, MD

Discover
Read: Contract Research Organization vs Clinical Research Organization (CRO vs CRO) Contract Research Organization vs Clinical Research Organization (CRO vs CRO)

Clinical Trials

Contract Research Organization vs Clinical Research Organization (CRO vs CRO)

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778858, hs_child_table_id=0, hs_updated_at=1744830865620, hs_published_at=1744844126301, description=Rob Maiale is a marketing strategist and creative technologist with 17 years of experience turning complex ideas into growth. He currently leads content strategy, where he transforms insights from Precision experts into market-shaping narratives that drive the advancement of next-generation therapies.  Rob’s career spans journalism, advertising, and brand storytelling, with a through-line of making the meaningful memorable. His work blends creative strategy with emerging AI tools to help Precision stay ahead of the curve—and above the noise., avatar=Image{width=400,height=400,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Rob%20Maiale.jpg',altText='Rob Maiale',fileId=184765575245}, linkedin=https://www.linkedin.com/in/rob-maiale/, hs_name=, hs_path=, lastname=Maiale, hs_initial_published_at=1744843965759, hs_created_at=1709645745089, hs_is_edited=false, hs_deleted_at=0, name=Rob, position=Associate Director, Digital Content & Inbound Marketing, job=, slug=rob-maiale, email=, hs_updated_by_user_id=51739740}, second={}, third={}})
  • Rob Maiale avatar

    Rob Maiale

Discover

Delivering Clinical Success Across Phases

  • Clinical Development Strategy

    Unlock the full potential of your clinical trials with our tailored Clinical Development Strategies. Designed to navigate the complexities of trial execution, Precision can propel your program toward accelerated success.

    Services Offered: 


    • Clinical Development Planning
    • Clinical Trial Design
    • Biomarker Trial Strategies
    • Basket, Master & Umbrella trials

    →LEARN MORE

    Clincal-dvp
  • Full-Service CRO

    Experience seamless integration and meticulous management of your clinical trial with our Full-Service CRO. We ensure every detail is managed with expertise to drive your study towards its successful completion.

    Services include, but are not limited to: 


    • Full-service Study Management
    • Study Start-up & Feasibility
    • Clinical Monitoring
    • Medical Monitoring
    • Drug Safety & Pharmacovigilance
    • Data Management
    • Biostatistics

    →LEARN MORE

    CRO
  • Precision FSP

    Amplify your clinical trial efficiency with Precision’s Functional Service Provider (FSP) solutions, offering specialized support focused on your project's unique needs.

    Solutions Offered:


    • FSP Clinical Monitoring
    • FSP Drug Safety & Pharmacovigilance
    • FSP Data Management
    • FSP Biostatistics
    • FSP Statistical Programming
    • FSP Medical Writing

    →LEARN MORE

    FSP

Advance therapeutic breakthroughs with Precision

Explore the breadth of our expertise in therapeutics and modalities, as we lead your novel treatments in Oncology, Rare Diseases and beyond, from the groundbreaking idea to clinical realization.

Specialized capabilities in every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to accelerate speed to market. Precision can customize and converge our capabilities to meet your program's unique needs—driving efficiency, agility, and success from start to finish.

  • Discover Explore
    clinical-trial-support

    Global CRO
    Services

    Award-winning CRO with deep oncology and rare disease expertise

    Explore
  • Discover Explore
    specialty-lab-services

    Global Laboratory
    Services

    Exceptional translational and biomarker sciences with global central lab services

    Explore